We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $127B
1-Year Est. Return 46.06%
This Fund
S&P 500
This Quarter Est. Return
+9.96%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$51.2B
AUM Growth
+$4.14B
Cap. Flow
+$2.35B
Cap. Flow %
4.58%
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.99B
2
MSFT icon
Microsoft
MSFT
+$522M
3
AMD icon
Advanced Micro Devices
AMD
+$511M
4
AMZN icon
Amazon
AMZN
+$318M
5
AAPL icon
Apple
AAPL
+$317M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$402M
2
MCD icon
McDonald's
MCD
+$375M
3
V icon
Visa
V
+$366M
4
META icon
Meta Platforms (Facebook)
META
+$319M
5
ADBE icon
Adobe
ADBE
+$272M

Sector Composition

Rank Sector Weight
1 Technology 19.66%
2 Healthcare 17.11%
3 Miscellaneous 15.83%
4 Consumer Discretionary 13.3%
5 Financials 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNRG icon
2626
Hallador Energy
HNRG
$797M
-33,413
Closed -$307K
HOWL icon
2627
Werewolf Therapeutics
HOWL
$47.6M
-120,936
Closed -$314K
HPQ icon
2628
CALL
HP
HPQ
$28.1B
-38,200
Closed -$1.12M
HPQ icon
2629
PUT
HP
HPQ
$28.1B
-53,700
Closed -$1.58M
HRL icon
2630
Hormel Foods
HRL
$11.7B
-76,748
Closed -$3.06M
HROW icon
2631
Harrow
HROW
$1.42B
-99,629
Closed -$2.11M
HRZN icon
2632
Horizon Technology Finance
HRZN
$326M
-18,297
Closed -$206K
HYEM icon
2633
VanEck Emerging Markets High Yield Bond ETF
HYEM
$518M
-276,173
Closed -$5.09M
HYG icon
2634
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.4B
-9,006
Closed -$672K
HYG icon
2635
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.4B
-234,700
Closed -$17.7M
HZO icon
2636
MarineMax
HZO
$1.15B
-18,342
Closed -$527K
IAT icon
2637
iShares US Regional Banks ETF
IAT
$650M
-23,300
Closed -$834K
IBM icon
2638
CALL
IBM
IBM
$219B
-34,200
Closed -$4.48M
IBM icon
2639
PUT
IBM
IBM
$219B
-119,900
Closed -$15.7M
IBRX icon
2640
ImmunityBio
IBRX
$8.79B
-234,441
Closed -$427K
ICUI icon
2641
ICU Medical
ICUI
$4.02B
-2,401
Closed -$396K
IDT icon
2642
IDT Corp
IDT
$1.7B
-14,580
Closed -$497K
IDYA icon
2643
IDEAYA Biosciences
IDYA
$3.75B
-27,903
Closed -$383K
IE icon
2644
Ivanhoe Electric
IE
$1.76B
-45,343
Closed -$551K
IEF icon
2645
PUT
iShares 7-10 Year Treasury Bond ETF
IEF
$42.1B
-9,700
Closed -$961K
IEO icon
2646
iShares US Oil & Gas Exploration & Production ETF
IEO
$633M
-3,500
Closed -$300K
IESC icon
2647
IES Holdings
IESC
$13.7B
-22,294
Closed -$480K
IEZ icon
2648
iShares US Oil Equipment & Services ETF
IEZ
$392M
-17,060
Closed -$330K
IGF icon
2649
iShares Global Infrastructure ETF
IGF
$10.5B
-22,334
Closed -$1.07M
IGMS
2650
DELISTED
IGM Biosciences
IGMS
-220,319
Closed -$3.03M

Similar funds

Marshall Wace's Q2 2023 Portfolio in Review

As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace deployed $2.35B of net new capital in Q2 2023, opening 648 new positions and adding to 710 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Gilead Sciences, an estimated $402M trimmed.

  • Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
  • Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
  • Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
  • Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
  • Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
  • Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
  • Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.